TCI Wealth Advisors, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,251
-5.4%
350.0%0.00%
Q4 2022$1,322
-33.9%
350.0%0.00%
Q3 2022$2,000
+100.0%
350.0%0.00%
Q2 2022$1,0000.0%350.0%0.00%
Q1 2022$1,0000.0%350.0%0.00%
Q4 2021$1,000
-83.3%
35
-79.9%
0.00%
-100.0%
Q3 2021$6,0000.0%174
+20.8%
0.00%0.0%
Q2 2021$6,000
+200.0%
144
+311.4%
0.00%0.0%
Q1 2021$2,0000.0%350.0%0.00%0.0%
Q4 2020$2,0000.0%350.0%0.00%0.0%
Q3 2020$2,0000.0%350.0%0.00%0.0%
Q2 2020$2,000
-33.3%
35
-34.0%
0.00%0.0%
Q1 2020$3,0000.0%530.0%0.00%0.0%
Q4 2019$3,000
-25.0%
53
-11.7%
0.00%
-50.0%
Q3 2019$4,0000.0%60
-9.1%
0.00%0.0%
Q2 2019$4,000
-20.0%
660.0%0.00%0.0%
Q1 2019$5,000
+25.0%
660.0%0.00%0.0%
Q4 2018$4,0000.0%66
-12.0%
0.00%0.0%
Q3 2018$4,0000.0%75
-19.4%
0.00%0.0%
Q2 2018$4,000
+33.3%
93
+40.9%
0.00%
+100.0%
Q1 2018$3,0000.0%660.0%0.00%0.0%
Q4 2017$3,0000.0%660.0%0.00%0.0%
Q3 2017$3,0000.0%660.0%0.00%
-50.0%
Q2 2017$3,0000.0%660.0%0.00%0.0%
Q1 2017$3,0000.0%66
+24.5%
0.00%0.0%
Q4 2016$3,000
-50.0%
53
-67.7%
0.00%
-33.3%
Q3 2016$6,000
+500.0%
164
+368.6%
0.00%
+200.0%
Q2 2016$1,0000.0%350.0%0.00%0.0%
Q1 2016$1,000
-50.0%
350.0%0.00%0.0%
Q4 2015$2,000350.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders